Sign In
Buy CNS
$76.14
+0.780 (+1.04%)
At Close: Jun 30, 2026
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
06:26pm, Monday, 29'th Jun 2026
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dist
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
06:23pm, Monday, 29'th Jun 2026
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
06:19pm, Monday, 29'th Jun 2026
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
06:04pm, Monday, 29'th Jun 2026
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the so
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
06:00pm, Monday, 29'th Jun 2026
NEW YORK, June 29, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of t
HOUSTON, June 25, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), announced today that it has s
Monthly Income Funds From Cohen & Steers (June Update)
05:02pm, Wednesday, 24'th Jun 2026
Cohen & Steers, Inc. offers institutional-quality closed-end funds focused on real assets and alternative income, with a recent real estate sell-off creating attractive entry points. Fund sectors incl
MapLight Therapeutics Announces Changes to Board of Directors
07:00am, Wednesday, 24'th Jun 2026
SAN FRANCISCO and BOSTON, June 24, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering
Reviva Pharmaceuticals to Present at the Life Sciences Investor Forum on June 24th
08:00am, Tuesday, 23'rd Jun 2026
CUPERTINO, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies
Plus Therapeutics to Provide Business Update Call on June 30, 2026
07:30am, Tuesday, 23'rd Jun 2026
Management to update on 2026 mid-year progress, milestones and provide details on its integrated CNS oncology strategy and artificial intelligence plans Management to update on 2026 mid-year progress,
Corero Network Security Expands Cybersecurity Reach Through Strategic Partnership with ITcare
07:00am, Tuesday, 23'rd Jun 2026
Partnership delivers real-time DDoS protection and cyber resilience solutions to enterprises, service providers, and critical infrastructure organizations LONDON, June 23, 2026 /PRNewswire/ -- Corero
Cohen & Steers Closed-End Funds Declare Distributions for July, August and September 2026
06:57pm, Monday, 22'nd Jun 2026
NEW YORK, June 22, 2026 /PRNewswire/ -- The Board of Directors of the Cohen & Steers Closed-End Funds announced today the monthly distributions for July, August and September 2026, as summarized in th
CAMBRIDGE, Mass., June 22, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and SK Biopharmaceutica
Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month
07:00am, Thursday, 18'th Jun 2026
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today an
Latus Bio Appoints Bethany Mancilla as Chief Business Officer
07:00am, Tuesday, 16'th Jun 2026
PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the appointment of Bethany Mancilla as Chief Business Offi
